7 September 2023
SHARE NOW
ATE
Automation & Digitisation
Strategy
Raja Sharif introduces this sessions focused on navigating the AI frontier, particularly in cell and gene therapy.
Raja Sharif, Founder & CEO, ATMPS, introduces Malik Kaman, Partner, ZS Consulting, who presents findings from a data collected from a pool of practitioners within the US about the challenges in cell and gene therapies.
Raja follows by diving into utilizing innovations outside from the healthcare industry to benefit from and reduce pain-points via automation and technology to increase access to cell and gene therapies.
Lastly, Martin Bornhauser, Professor, University Hospital Dresden presents the newly joint Hataali AI product ‘SARA’.
This session is then followed by a panel discussion to conclude.
This Briefing was recorded at Advanced Therapies Europe 2023.
More like this
Cell and Gene Therapies News Round-Up: October 11
Welcome to Phacilitate’s weekly news round-up, which will bring you the latest advanced therapies news and resources each Friday in the lead up to Advanced Therapies Week 2025 in Dallas. This round-up covers manufacturing, investment, therapeutic development, clinical trials, and any stories making the headlines that week.
11 October 2024
